Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-65
SponsorMassachusetts General Hospital
About this trial
The plot study aims to evaluate the effect of 8 weeks of stress reducing intervention on atherosclerotic plaque inflammation in adults, as quantified by positron emission tomography (PET) with fluorine-2-deoxy-D-glucose (FDG) in individuals with increased psychosocial stress.
Eligibility criteria
Qualifiers
• Aged between 30-65 years
Identifies as having increased levels of stress and/or has a Perceived Stress Scale (PSS) score >5 at baseline, and is interested in participating
Disqualifiers
Perceived Stress Scale (PSS) score <6
Trial design
Treatments tested in this trial
- Stress Reduction
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov